Next Science Limited is a medical technology company headquartered in Sydney, Australia, with a research and development centre in Florida, USA. It is listed on the ASX under ASX Code ‘NXS’. Next Science’s primary focus is the development and continued commercialisation of its proprietary XbioTM technology to reduce the impact of biofilm based infections in human health.

Shareholder meetings

AGM 2020

Date & Time
10.00am, Wednesday, 6 May 2020

Webcast
The AGM was webcast live. An archive of this is available at:
https://webcast.openbriefing.com/6064/Opens in new window

Information
Notice of 2020 AGM Opens in new window
Virtual Meeting Guide Opens in new window
2019 Annual Report Opens in new window

Investor contacts

Investor queries

Next Science Limited
Level 19, Tower A, The Zenith
821 Pacific Highway, Chatswood
NSW 2067
Ph: +61 2 9375 7989
E: [email protected]

Share Registry queries

Link Market Services Limited
Level 12, 680 George Street
Sydney NSW 2000
Ph: 1300 554 474